Ursula Matulonis Explains the Use of PARP Inhibitors for Ovarian Cancer
March 13th 2017Ursula Matulonis, M.D., professor of Medicine, Harvard Medical School, Medical Director of Gynecologic Oncology, Dana-Farber Cancer Institute, explains the benefits of PARP inhibitors for patients with ovarian cancer.